Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelitis NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02853929
What this trial is testing

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
DiphtheriaHepatitis BAcellular Pertussis+4 more
GlaxoSmithKline 551
Early research (Phase 1)Study completedNCT01571505
What this trial is testing

Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)

Who this might be right for
PoliomyelitisTropical Enteropathy
International Vaccine Institute 372
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Post-approval studies (Phase 4)WithdrawnNCT00037115
What this trial is testing

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Who this might be right for
Demyelinating DisordersMultiple SclerosisOptic Neuritis+2 more
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Post-approval studies (Phase 4)Study completedNCT01831050
What this trial is testing

Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

Who this might be right for
Poliomyelitis
Fidec Corporation 1,420
Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Testing effectiveness (Phase 2)Study completedNCT00133445
What this trial is testing

Pentavalent DTaP-Hep B-IPV

Who this might be right for
DiphtheriaHepatitis BPoliomyelitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Not applicableEnded earlyNCT00519181
What this trial is testing

Safety and Efficiency Study of Valproic Acid In HAM/TSP

Who this might be right for
HTLV-I-Associated Myelopathy
University Hospital Pierre Zobda-Quitman 19
Early research (Phase 1)Study completedNCT06101173
What this trial is testing

Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Who this might be right for
Poliomyelitis
CanSino Biologics Inc. 72
Not applicableLooking for participantsNCT05909761
What this trial is testing

Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

Who this might be right for
Neuromyelitis Optica Spectrum DisorderPregnancy Related
Amgen 60
Post-approval studies (Phase 4)UnknownNCT02021825
What this trial is testing

Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorders
Xuanwu Hospital, Beijing 50
Large-scale testing (Phase 3)Study completedNCT00337428
What this trial is testing

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 843
Not applicableUnknownNCT01024985
What this trial is testing

Evaluation of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Oct

Who this might be right for
Multiple SclerosisNeuromyelitis Optica
University of Sao Paulo 40
Not applicableStudy completedNCT02815878
What this trial is testing

Enhance Wellness for Individuals With Long-Term Physical Disabilities

Who this might be right for
Multiple SclerosisMuscular DystrophyPost-polio Syndrome+1 more
University of Washington 240
Post-approval studies (Phase 4)Study completedNCT06442449
What this trial is testing

Booster Dose of sIPV Co-administered With MMR and HepA-I.

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 889
Large-scale testing (Phase 3)Study completedNCT01287949
What this trial is testing

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Who this might be right for
DiphtheriaTetanusPoliomyelitis+1 more
Sanofi Pasteur, a Sanofi Company 342
Large-scale testing (Phase 3)Study completedNCT01245049
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

Who this might be right for
Acellular PertussisPoliomyelitisTetanus+1 more
GlaxoSmithKline 387
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Early research (Phase 1)Study completedNCT01997632
What this trial is testing

Phase 1 Study on the Safety and Reactogenicity of a Single Dose of Monovalent High-dose Inactivated Poliovirus Type 2 Vaccine (m-IPV2 HD) Given Intramuscularly Compared to Standard Trivalent Inactivated Poliovirus Vaccine (IPV) in Healthy Adults

Who this might be right for
Poliomyelitis
University Hospital, Ghent 120
Next Page